Laurie Freire Boullosa

4PUBLICATIONS
18CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 29, 2023
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.

Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser

|Mar 27, 2023
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.

Tal Flieswasser, Astrid Van den Eynde, Laurie Freire Boullosa

|Jan 24, 2020
New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia.

Stephanie Jordaens, Leah Cooksey, Laurie Freire Boullosa

Pageof 1